Hi-Tech Pharmacal Co. 

(Public, NASDAQ:HITK)   Watch this stock   
Find more results for HITK
Nov 12, 2009
Annual Meeting of Stockholders
Sep 9, 2009
Q1 2010 Earnings Conference Call
Sep 9, 2009
Q1 2010 Earnings Release
More events from AOL Finance »    

Key stats and ratios

Q3 (Jul '09) 2009
Net profit margin 19.95% 9.04%
Operating margin 31.87% 14.59%
EBITD margin - 14.06%
Return on average assets 30.18% 10.21%
Return on average equity 38.18% 12.16%
Employees 366 -

Address

369 Bayview Avenue
Amityville, NY 11701
United States - Map
+1-631-7898228 (Phone)
+1-631-7898429 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance

Hi-Tech Pharmacal Co. discussions

  View all discussions »

Description

Hi-Tech Pharmacal Co., Inc. (Hi-Tech) is a specialty manufacturer and marketer of prescription, over-the-counter (OTC) and nutritional products. The Company develops, manufactures and markets products in three categories: generics, prescription brands and OTC brands. It produce a range of products for various disease states, including asthma, bronchial disorders, dermatological disorders, allergies, pain, stomach, oral care, neurological disorders, glaucoma and other conditions. The Company’s generic products are primarily prescription items and include oral solutions and suspensions, topical creams and ointments, as well as nasal sprays. It also specializes in the manufacture of products in its sterile facility capable of producing liquid ophthalmic, otic and inhalation products. On February 27, 2009, the Company purchased substantially all of the assets of E. Claiborne Robins Company, Inc. doing business as, ECR Pharmaceuticals (ECR Pharmaceuticals or ECR).

Officers and directors

David S. Seltzer
Chairman of the Board, President, Chief Executive Officer, Secretary, Treasurer
Age: 49
Bio & Compensation - Reuters
William Peters
Chief Financial Officer, Vice President
Age: 41
Bio & Compensation - Reuters
Gary M. April
President - Health Care Products Division
Age: 52
Bio & Compensation - Reuters
Bryce M. Harvey
President - Midlothian Laboratories Division
Age: 53
Bio & Compensation - Reuters
Davis S. Caskey
Vice President - Pharmaceutical Operations of ECR Pharmaceuticals Co., Inc
Age: 61
Bio & Compensation - Reuters
Reuben Seltzer
Director
Age: 53
Bio & Compensation - Reuters
Martin M. Goldwyn
Director
Age: 57
Bio & Compensation - Reuters
Yashar Hirshaut M.D.
Director
Age: 71
Bio & Compensation - Reuters
Anthony J. Puglisi
Director
Age: 60
Bio & Compensation - Reuters
Bruce W. Simpson
Director
Age: 67
Bio & Compensation - Reuters